Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Collichio · SciRah

Researcher profile · Semantic Scholar

F. Collichio

Share profile

F. Collichio — researcher profile on SciRah

h-index: 31
Works: 120
Citations: 9,040

Most-cited papers

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
R. Andtbacka, H. Kaufman, F. Collichio, T. Amatruda +25 more
2015Journal of Clinical Oncology2,369 citations
Semantic Scholar
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
J. Chesney, I. Puzanov, F. Collichio, Parminder Singh +14 more
2017Journal of Clinical Oncology566 citations Open access
Semantic Scholar
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
F. Hodi, C. Corless, A. Giobbie-Hurder, J. Fletcher +20 more
2013Journal of Clinical Oncology559 citations Open access
Semantic Scholar
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
R. Andtbacka, F. Collichio, K. Harrington, M. Middleton +3 more
2019Journal of Immunotherapy for Cancer417 citations Open access
Semantic Scholar
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
R. Andtbacka, M. Ross, I. Puzanov, M. Milhem +9 more
2016Annals of Surgical Oncology308 citations Open access
Semantic Scholar
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma.
S. O'Day, A. Eggermont, V. Chiarion-Sileni, R. Kefford +15 more
2013Journal of Clinical Oncology263 citations Open access
Semantic Scholar
OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.
H. Kaufman, R. Andtbacka, F. Collichio, T. Amatruda +10 more
2013Journal of Clinical Oncology171 citations
Semantic Scholar
Ipilimumab with or without nivolumab in PD1/PDL1 blockade refractory metastatic melanoma: a randomized phase 2 trial
A. Vanderwalde, Shay Bellasea, K. Kendra, N. Khushalani +29 more
2023Nature Medicine164 citations Open access
Semantic Scholar
Historical review of melanoma treatment and outcomes.
Ca-Young Lee, F. Collichio, D. Ollila, S. Moschos
2013Clinical Dermatology90 citations
Semantic Scholar
Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.
R. Louie, M. Perez, M. R. Jajja, James X. Sun +6 more
2019Journal of the American College of Surgeons89 citations
Semantic Scholar
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial
J. Chesney, I. Puzanov, F. Collichio, Parminder Singh +12 more
2023Journal for ImmunoTherapy of Cancer85 citations Open access
Semantic Scholar
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
K. Harrington, R. Andtbacka, F. Collichio, G. Downey +3 more
2016OncoTargets and Therapy82 citations Open access
Semantic Scholar
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy
O. Kaidar-Person, T. Zagar, A. Deal, S. Moschos +7 more
2017Anti-Cancer Drugs70 citations
Semantic Scholar
Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into?
T. Shanafelt, Marilyn J. Raymond, L. Horn, T. Moynihan +6 more
2014Journal of Clinical Oncology55 citations Open access
Semantic Scholar
Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factors.
M. Waddle, Ronald C. Chen, N. Arastu, R. Green +5 more
2015Practical Radiation Oncology47 citations
Semantic Scholar
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
H. Kaufman, R. Andtbacka, F. Collichio, M. Wolf +4 more
2017Journal of Immunotherapy for Cancer46 citations Open access
Semantic Scholar
Concurrent Temozolomide and Radiation, a Reasonable Option for Elderly Patients With Glioblastoma Multiforme?
R. Kimple, S. Grabowski, M. Papez, F. Collichio +2 more
2009American Journal of Clinical Oncology41 citations
Semantic Scholar
Integrating Palliative and Oncology Care for Patients with Advanced Cancer: A Quality Improvement Intervention
L. Hanson, F. Collichio, S. Bernard, W. Wood +8 more
2017Journal of Palliative Medicine40 citations Open access
Semantic Scholar
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
Michael J. Carr, James X. Sun, Danielle K. DePalo, L. Rothermel +16 more
2021Annals of Surgical Oncology35 citations
Semantic Scholar
Parental Leave in Graduate Medical Education: Recommendations for Reform.
Patricia Vassallo, Jennifer Jeremiah, L. Forman, Lauralee Dubois +5 more
2019American Journal of Medicine35 citations Open access
Semantic Scholar
Primary results from a randomized (1:1), open-label phase II study of talimogene laherparepvec (T) and ipilimumab (I) vs I alone in unresected stage IIIB- IV melanoma.
J. Chesney, I. Puzanov, M. Ross, F. Collichio +6 more
201732 citations
Semantic Scholar
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
J. Chesney, I. Puzanov, F. Collichio, M. Milhem +6 more
2019British Journal of Cancer31 citations Open access
Semantic Scholar
Guidelines for a Standardized Fellowship Letter of Recommendation.
R. Alweis, F. Collichio, C. Milne, B. Dalal +4 more
2017American Journal of Medicine30 citations Open access
Semantic Scholar
Utility of Susceptibility Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma
Ana M. Franceschi, S. Moschos, C. Anders, Samuel A. Glaubiger +4 more
2016Journal of computer assisted tomography30 citations Open access
Semantic Scholar
Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704)
R. Andtbacka, F. Collichio, T. Amatruda, N. Senzer +12 more
2014Journal of Immunotherapy for Cancer28 citations Open access
Semantic Scholar
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
E. Dees, B. O'Neil, C. Lindley, F. Collichio +6 more
2008Cancer Chemotherapy and Pharmacology27 citations Open access
Semantic Scholar
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
D. Trembath, E. Davis, Shanti G. Rao, Evan Bradler +14 more
2021Frontiers in Oncology26 citations Open access
Semantic Scholar
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
Mazen Al Mushref, Paul A. Guido, F. Collichio, D. Moore +1 more
2019Endocrine Practice26 citations
Semantic Scholar
A PHASE 2 STUDY OF ONTUXIZUMAB, A MONOCLONAL ANTIBODY TARGETING ENDOSIALIN, IN METASTATIC MELANOMA
S. D'Angelo, O. Hamid, A. Tarhini, D. Schadendorf +9 more
2017Investigational new drugs26 citations Open access
Semantic Scholar
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series
A. Naqash, D. File, Carolyn M. Ziemer, Y. Whang +3 more
2019Journal of Immunotherapy for Cancer25 citations Open access
Semantic Scholar
How well do documented goals-of-care discussions for patients with stage IV cancer reflect communication best practices?
Natalie C. Ernecoff, K. Wessell, W. Wood, Gary S. Winzelberg +2 more
2020BMC Palliative Care24 citations Open access
Semantic Scholar
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review
P. Dillon, Nancy E. Thomas, N. Sharpless, F. Collichio
2009Medical Oncology20 citations Open access
Semantic Scholar
Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC).
H. Kaufman, T. Amatruda, J. Nemunaitis, J. Chesney +7 more
201519 citations
Semantic Scholar
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Z. Eroglu, K. Broman, John F. Thompson, A. Nijhuis +43 more
2022Journal for ImmunoTherapy of Cancer17 citations Open access
Semantic Scholar
Vemurafenib‐Associated Pancreatitis: Case Report
B. Muluneh, L. Buie, F. Collichio
2013Pharmacotherapy17 citations
Semantic Scholar
Efficacy of a Dual-epitope DC Vaccine as Part of Combined Immunotherapy for HER2-expressing Breast Tumors
B. Vincent, D. File, K. McKinnon, D. Moore +14 more
2023Journal of Immunology16 citations Open access
Semantic Scholar
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma
J. Oldan, B. Giglio, E. Smith, Wei Zhao +19 more
2022medRxiv15 citations Open access
Semantic Scholar
Shackled: The Challenge of Caring for an Incarcerated Patient
Andrew M. Courtwright, Theresa Raphael-Grimm, F. Collichio
2008The American journal of hospice & palliative care15 citations
Semantic Scholar
Interim safety and efficacy of a randomized (1:1), open-label phase 2 study of talimogene laherparepvec (T) and ipilimumab (I) vs I alone in unresected, stage IIIB-IV melanoma
J. Chesney, F. Collichio, R. Andtbacka, I. Puzanov +9 more
201614 citations Open access
Semantic Scholar
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance
F. Collichio, Brian J. Hess, E. Muchmore, Lauren M. Duhigg +8 more
2016Journal of Cancer Education14 citations
Semantic Scholar
Development of an Art of Oncology Curriculum to Mitigate Burnout and Foster Solidarity Among Hematology/Oncology Fellows.
Daniel R. Richardson, Xian-Ming Tan, Gary S. Winzelberg, D. Rosenstein +1 more
2020JCO Oncology Practice13 citations
Semantic Scholar
Abstract CT013: S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with metastatic or unresectable melanoma that did not respond to anti-PD-1 therapy
A. Vanderwalde, J. Moon, K. Kendra, N. Khushalani +10 more
2022Cancer Research12 citations
Semantic Scholar
Mortality Risk for Patients With Stage IV Cancer and Acute Illness Hospitalization
L. Hanson, Natalie C. Ernecoff, K. Wessell, Feng-Chang Lin +4 more
2020Journal of Pain and Symptom Management12 citations Open access
Semantic Scholar
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience
G. Karachaliou, Fatih Ayvali, F. Collichio, Carrie Lee +3 more
2019Oncology12 citations
Semantic Scholar
Implementing a Program of Talimogene laherparepvec
F. Collichio, Lauren M. B. Burke, A. Proctor, D. Wallack +3 more
2018Annals of Surgical Oncology12 citations
Semantic Scholar
Targeting the IL-2 Inducible Kinase in Melanoma; A Phase 2 Study of Ibrutinib in Systemic Treatment-Refractory Distant Metastatic Cutaneous Melanoma: Preclinical Rationale, Biology, and Clinical Activity (NCI9922)
S. Moschos, Z. Eroglu, N. Khushalani, K. Kendra +22 more
2021Melanoma research10 citations Open access
Semantic Scholar
A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study
J. Bischof, Montika Bush, Rayad Bin Shams, F. Collichio +1 more
2021Supportive Care in Cancer9 citations Open access
Semantic Scholar
Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase II trial
J. Chesney, I. Puzanov, F. Collichio, Parminder Singh +12 more
2019Annals of Oncology9 citations Open access
Semantic Scholar
Internal medicine fellowship directors’ perspectives on the quality and utility of letters conforming to residency program director letter of recommendation guidelines
Alec B. O’Connor, C. M. Williams, B. Dalal, M. S. Sulistio +5 more
2018Journal of Community Hospital Internal Medicine Perspectives9 citations Open access
Semantic Scholar
Systematic Review: Surgery for Patients with Metastatic Melanoma during Active Treatment with Ipilimumab
J. Baker, K. Stitzenberg, F. Collichio, M. Meyers +1 more
2014The American surgeon9 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Andtbacka×11
Invite
R. Andtbacka — researcher profile on SciRah
J. Chesney×10
Invite
J. Chesney — researcher profile on SciRah
I. Puzanov×10
Invite
I. Puzanov — researcher profile on SciRah
D. Ollila×10
Invite
D. Ollila — researcher profile on SciRah

×9

Invite

H. Kaufman — researcher profile on SciRah

Invite

M. Milhem — researcher profile on SciRah

Invite

M. Ross — researcher profile on SciRah

Invite

K. Delman — researcher profile on SciRah

Invite

S. Moschos — researcher profile on SciRah

Invite

C. Garbe — researcher profile on SciRah

A. Hauschild×6

Invite

A. Hauschild — researcher profile on SciRah

Invite

Lisa Chen — researcher profile on SciRah